Literature DB >> 4628896

Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia.

G E Kenny, B B Wentworth, R P Beasley, H M Foy.   

Abstract

Immunoelectroosmophoresis with rabbit anticapsular antibody was used to detect type-specific pneumococcal polysaccharide in serum from bacteremic patients with pneumococcal pneumonia. The test could detect as little as 0.1 to 1.0 mug per ml or 0.2 to 2 ng per test of polysaccharide from types 1, 2, 3, 4, 5, 8, 12, and 18, and its sensitivity was 10 times that of double immunodiffusion. Although antigen could be detected by double immunodiffusion with types 7 and 14, no antigen could be detected by immunoelectroosmophoresis. Types 7 and 14 polysaccharides were found to be positively charged, whereas the other polysaccharides were negatively charged. Forty-six patients with pneumonia were selected for study because pneumococci corresponding to those types where the test was known to work had been isolated from blood or the respiratory tract. Antigenemia correlated strongly with bacteremia: 12 of 20 bacteremic patients with pneumonia showed antigenemia, whereas 26 patients negative for bacteremia did not show circulating antigen detectable with antisera against the pneumococcal type isolated from the respiratory tract. The apparent concentration of circulating polysaccharide ranged from 0.1 to 100 mug per ml of serum, and the concentration did not appear to diminish appreciably in 10 to 15 days. Three of 12 patients with antigenemia died, and two of these had the highest levels of circulating antigen observed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4628896      PMCID: PMC422555          DOI: 10.1128/iai.6.4.431-437.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Analysis of serum pooling schemes for identification of large numbers of viruses.

Authors:  G E Kenny; M K Cooney; D J Thompson
Journal:  Am J Epidemiol       Date:  1970-04       Impact factor: 4.897

2.  Types of pneumococci found in blood, spinal fluid and pleural exudate during a period of 15 years (1954-1969).

Authors:  E Lund
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

3.  The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia.

Authors:  E Barrett-Connor
Journal:  Am Rev Respir Dis       Date:  1971-06

4.  Detection by immunoelectrophoresis of antigen in sera of patients with pneumococcal bacteraemia.

Authors:  G J Dorff; J D Coonrod; M W Rytel
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

5.  Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections.

Authors:  B M Greenwood; H C Whittle; O Dominic-Rajkovic
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

6.  Relative sensitivity of gel diffusion, complement fixation, and immunoelectroosmophoresis tests for detection of hepatitis-associated antigen and antibody.

Authors:  N J Schmidt; P S Gee; E H Lennette
Journal:  Appl Microbiol       Date:  1971-08

7.  Comparison of three serological methods for the detection of hepatitis-associated antigen.

Authors:  G B White; R M Lasheen; M B Baillie; G C Turner
Journal:  J Clin Pathol       Date:  1971-02       Impact factor: 3.411

8.  Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation.

Authors:  H J Alter; P V Holland; R H Purcell
Journal:  J Lab Clin Med       Date:  1971-06

9.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03

10.  Serological comparison of ten glycolytic Mycoplasma species.

Authors:  G E Kenny
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

View more
  32 in total

1.  Use of Counter and rocket immunoelectrophoresis in acute respiratory infections due to Streptococcus pneumoniae.

Authors:  R C Spencer; M A Savage
Journal:  J Clin Pathol       Date:  1976-03       Impact factor: 3.411

2.  Lung bacterial clearance in murine pneumococcal pneumonia.

Authors:  M J Ansfield; D E Woods; W G Johanson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

3.  Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.

Authors:  R K Dhingra; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

4.  Minimum number of pneumococci required for capsular antigen to be detectable by latex agglutination.

Authors:  Y Holloway; W G Boersma; H Kuttschrütter; J A Snijder
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

5.  Diagnosis of pneumococcal pneumonia by antigen detection in sputum.

Authors:  J Miller; M A Sande; J M Gwaltney; J O Hendley
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

6.  Counterimmunoelectrophoresis of pneumococcal antigens:improved sensitivity for the detection of types VII and XIV.

Authors:  J P Anhalt; P K Yu
Journal:  J Clin Microbiol       Date:  1975-12       Impact factor: 5.948

7.  Immunochemical analysis of streptococcal group A, B, and C carbohydrates, with emphasis on group A.

Authors:  J C Fung; K Wicher; M McCarty
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

8.  Demonstration of circulating pneumococcal immunoglobulin G immune complexes in patients with community-acquired pneumonia by means of an enzyme-linked immunosorbent assay.

Authors:  Y Holloway; J A Snijder; W G Boersma
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

9.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  Immunogenicity and antigenicity of human coronaviruses 229E and OC43.

Authors:  O W Schmidt; G E Kenny
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.